Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
OPKO Health, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
OPK
Nasdaq
2830
www.opko.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for OPKO Health, Inc.
SOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.Therapy
- Oct 23rd, 2026 9:19 am
FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI
- Oct 23rd, 2026 7:55 am
GEHC Expands Theranostics Imaging With 5 Global Collaborations
- Oct 22nd, 2026 7:42 am
Revvity Launches Signals LabGistics to Coordinate Scientific Workflows
- Oct 22nd, 2026 7:34 am
Stryker's Sonopet 3 Secures FDA Clearance to Improve Surgical Accuracy
- Oct 21st, 2026 5:14 am
OPKO Health (OPK) Sells BioReference Assets On A Valuation Story That Still Divides
- Oct 17th, 2026 12:14 pm
Is OPKO Health (OPK) Pricing In Too Much For Sales?
- Oct 17th, 2026 7:16 am
OPKO Health to Sell Select BioReference Assets to Labcorp for $722M
- Oct 16th, 2026 8:20 am
BD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients
- Oct 15th, 2026 10:22 am
Labcorp outlays up to $872m to acquire BioReference’s laboratory assets
- Oct 15th, 2026 10:11 am
Labcorp to buy BioReference assets for up to $872M
- Oct 15th, 2026 9:18 am
Doximity Deepens U.S. News Alliance to Improve Patient Access to Care
- Oct 15th, 2026 8:45 am
Opko Health stock soars on $722M BioReference asset sale
- Oct 15th, 2026 7:45 am
Natera Gains 118.1% in a Year: What's Driving the Rally?
- Oct 15th, 2026 6:28 am
West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?
- Oct 15th, 2026 6:25 am
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
- Oct 15th, 2026 5:30 am
Glaukos Stock Gains 36.8% in 6 Months: What's Behind the Rally?
- Oct 14th, 2026 10:36 am
VEEV Expands IQVIA Partnership With Clinical Operations Software Suite
- Oct 14th, 2026 7:44 am
BTSG Stock Climbs 67.3% YTD: What's Driving the Rally in 2026?
- Oct 14th, 2026 7:42 am
Scroll